Brief: Emcure Pharmaceuticals Says Novo Nordisk Partners With Emcure To Commercialise Poviztra In India
10/11/2025 05:53
Nov 10 (Reuters) - Emcure Pharmaceuticals Ltd EMCU.NS: EMCURE PHARMACEUTICALS LTD - NOVO NORDISK PARTNERS WITH EMCURE TO COMMERCIALISE POVIZTRA IN INDIA EMCURE PHARMACEUTICALS LTD - TO BE EXCLUSIVE DISTRIBUTOR FOR POVIZTRA IN INDIA Source text: ID:nNSE2Fxdb5 Further company coverage: EMCU.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Emcure Pharmaceuticals
See all newsIndia's Emcure Pharma rises on Poviztra approval, Motilal initiation with 'buy'
Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
Brief: Emcure Pharmaceuticals Says Kuber Jagdale, President, API Business, Superannuates
India's Emcure Pharma hits record high after Jefferies raises TP
Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees